2013

• Soon, P., Kim, E., Pon, C., Gill, A., Moore, K., Spillane, A., Benn, D., Baaxter, R. (2013), Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocrine-Related Cancer. 20(1), 1-12. [Abstract]

2012

• Cusack, L., Brennan, M., Weissenberg, L., Moore, K. (2012), Breast clinic triage tool: Telephone assessment of new referrals. Breast. 21(2), 215-217. [Abstract]

2011

• Elder, E., Hay, S., Moore, K. (2011), Factors influencing treatment recommendations in node-negative breast cancer. Journal of Oncology Practice. 7(1), 26-30. [Abstract]

2009

• Sarma, S., Ying, T., Moore, K. (2009), Long-term vaginal ring pessary use: discontinuation rates and adverse events. BJOG : an international journal of obstetrics and gynaecology. 116(13), 1715-21. [Abstract]

2008

• Allen, W., Leek, H., Izurieta, A., Moore, K. (2008), Update: the "Contiform" intravaginal device in four sizes for the treatment of stress incontinence. International urogynecology journal and pelvic floor dysfunction. 19(6), 757-61. [Abstract]
• Morris, A., Westbrook, J., Moore, K. (2008), A longitudinal study over 5 to 10 years of clinical outcomes in women with idiopathic detrusor overactivity. BJOG : an international journal of obstetrics and gynaecology. 115(2), 239-46. [Abstract]

2007

• Moore, K., Sweeney, K., Wilson, M., Goldberg, J., Buchanan, C., Tan, L., Liberman, L., Turner, R., Lagios, M., Cody Iii, H., Giuliano, A., Silverstein, M., Van Zee, K. (2007), Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Annals of surgical oncology. 14(10), 2911-2917. [Abstract]
• Foote, A., Moore, K. (2007), The cost of urogynaecological treatments: which are more cost-effective?. The Australian & New Zealand journal of obstetrics & gynaecology. 47(3), 240-6. [Abstract]